On 25 November, Clariane will sponsor two major plenary keynotes within the Care & Assistance vertical at WMIF 2025, gathering international experts to discuss the evolving landscape of psychiatric care and diagnosis.
That same afternoon, Clariane will also host four in-depth sessions in the Thematic Area, reinforcing its contribution to the forum’s discussions on mental health, innovative therapies and care solutions.
Plenary sessions
12:15h – 13:00h | Precision Medicine in Psychiatry
Dr. Eduard Vieta and Dr. Maria Isabel Arguello, exploring how inflammatory processes intersect with psychiatric disorders, opening new avenues for diagnosis and treatment.
13:00h – 13:45h | ADHD in Adults: A Novel, Patient-Centered Solution for Healthcare Systems
Dr. Aaron Winkler and Dr. Amine Benyamina, examining the nuances of ADHD diagnosis across populations.
Afternoon deep dive: Innovation Days at WMIF
15:30h – 15:45h | Key Issues in Health Innovation
Anne-Charlotte Dymny and Prof. Antoine Piau, from Clariane France
15:45h – 16:15h | GLP-1 Agonists in Psychiatry: State of the Art for Clinicians
Dr. Philippe Nuss, on metabolic treatments for mental disorders.
16:15h – 16:45h | Rehabilitation in Eating Disorders
Dr. Antonio Sarnicola and Dr. Antoni Grau, focusing on therapeutic interventions beyond medication.
16:45h – 17:15h | Brain stimulation in Eating Disorders
Dr. Luis Beato-Fernández, discussing neuromodulation techniques.
17:15h – 17:45h | New Addictions / New Challenges
With Dr. Benjamin Rolland, addressing public health risks from emerging psychoactive substances.
By aligning this initiative with WMIF 2025, Clariane reinforces its position as a thought leader in the care ecosystem, committed to person-centred, science-driven innovation in mental health and psychiatric care.
